LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Apr 21, 2020
Product Development
Trio of tactics to target COVID-19 hyperinflammation
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Read More
BioCentury
|
Feb 21, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Jan 31, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Aug 22, 2017
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Aug 11, 2017
Tools & Techniques
K follows C in chemoproteomics
Chemoproteomic mapping of druggable lysines in the proteome
Read More
BioCentury
|
Nov 11, 2016
Tools & Techniques
Chemistry beyond candidates
AZN chemists tackle common problems in compound innovation
Read More
BioCentury
|
Nov 4, 2013
Finance
Calithera metabolizes
Calithera's second act as cancer metabolism play attracts $35M
Read More
BioCentury
|
Nov 11, 2010
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Aug 30, 2010
Company News
Aileron, Roche deal
Read More
BioCentury
|
Aug 30, 2010
Product Development
Roche Goes Shopping for Staples
Roche increases commitment to Stapled Peptides technology at Aileron Therapeutics
Read More
Items per page:
10
1 - 10 of 33
Help Center
Username
Request Training
Ask a Question
Request a Demo
Elevio by Dixa
Help